Hyperglycemia induced down-regulation of renal P-glycoprotein expression

European Journal of Pharmacology

Volumn 690, Issue 1-3, 2012, Pages 42-50

  Yeh, Szu Yu ^a   Pan, Huei Ju ^b   Lin, Chung Cheng ^a   Kao, Yu Han ^a   Chen, Yen Hui ^b   Lin, Chun Jung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Diabetes; Kidney; P glycoprotein; PKC; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; DIGOXIN; DIGOXIN H 3; GLUCOSE; GLUTATHIONE; GLYCOPROTEIN P; INSULIN; INTERLEUKIN 6; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; RUBOXISTAURIN; STAUROSPORINE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CELL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BODY WEIGHT; CELL MEMBRANE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIGOXIN; DOGS; DOWN-REGULATION; FEMALE; HYPERGLYCEMIA; INSULIN; INTERLEUKIN-6; KIDNEY; MADIN DARBY CANINE KIDNEY CELLS; MALE; MICE; P-GLYCOPROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864468778     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.06.013     Document Type: Article

References (38)

1. S. Ahmad, A.R. Safa, and R.I. Glazer Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system Biochemistry 33 1994 10313 10318
2. D.A. Allen, S. Harwood, M. Varagunam, M.J. Raftery, and M.M. Yaqoob High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases FASEB J. 17 2003 908 910
3. B. Bauer, A.M. Hartz, and D.S. Miller Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier Mol. Pharmacol. 71 2007 667 675
4. M. Bielschowsky, and C.M. Goodall Origin of inbred NZ mouse strains Cancer Res. 30 1970 834 836
5. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
6. C. Cordon-Cardo, J.P. O'Brien, D. Casals, L. Rittman-Grauer, J.L. Biedler, M.R. Melamed, and J.R. Bertino Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc. Nat. Acad. Sci. U.S.A. 86 1989 695 698
7. R.G. del Moral, A. Olmo, M. Aguilar, and O. Valle, F. P-glycoprotein: a new mechanism to control drug-induced nephrotoxicity Exp. Nephrol. 6 1998 89 97
8. M.T. Diaz-Meco, E. Berra, M.M. Municio, L. Sanz, J. Lozano, I. Dominguez, V. Diaz-Golpe, M.T. Lain De Lera, J. Alcami, C.V. Paya, F. Arenzana-Seisdedos, J. Virelizier, and J. Moscat A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation Mol. Cell. Biol. 13 1993 4770 4775
9. K. Doi, and K. Ishida Diabetes and hypertriglyceridemia modify the mode of acetaminophen-induced hepatotoxicity and nephrotoxicity in rats and mice J. Toxicol. Sci. 34 2009 1 11
10. R.A. Felix, and M.A. Barrand P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress J. Neurochem. 80 2002 64 72
11. R.L. Fine, T.C. Chambers, and C.W. Sachs P-glycoprotein, multidrug resistance and protein kinase C Oncologist 1 1996 261 268
12. A.T. Fojo, K. Ueda, D.J. Slamon, D.G. Poplack, M.M. Gottesman, and I. Pastan Expression of a multidrug-resistance gene in human tumors and tissues Proc. Nat. Acad. Sci. U.S.A. 84 1987 265 269
13. U.A. Germann, T.C. Chambers, S.V. Ambudkar, T. Licht, C.R. Cardarelli, I. Pastan, and M.M. Gottesman Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells J. Biol. Chem. 271 1996 1708 1716
14. H.R. Goodfellow, A. Sardini, S. Ruetz, R. Callaghan, P. Gros, P.A. McNaughton, and C.F. Higgins Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein J. Biol. Chem. 271 1996 13668 13674
15. S.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Sciences 259 1993 87 91
16. J.S. Huang, L.Y. Chuang, J.Y. Guh, Y.J. Huang, and M.S. Hsu Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells Am. J. Physiol. Renal Physiol. 293 2007 F1072 F1082
17. M. Huls, C. Kramers, E.N. Levtchenko, M.J.G. Wilmer, H.B.P.M. Dijkman, L.A.J. Kluitmans, J.W.A. van der Hoorn, F.G.M. Russel, and R. Masereeuw P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury Kidney Int. 72 2007 1233 1241
18. P.A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am. J. Physiol. Endocrinol. Metab. 280 2001 E745 E751
19. E.H. Leiter Nonobese diabetic mice and the genetics of diabetes susceptibility Curr. Diab. Rep. 5 2005 141 148
20. E.H. Leiter, P.C. Reifsnyder, K. Flurkey, H.J. Partke, E. Junger, and L. Herberg NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds Diabetes 47 1998 1287 1295
21. H.-J. Maeng, M.-H. Kim, H.-E. Jin, S.M. Shin, T. Tsuruo, S.G. Kim, D.-D. Kim, C.-K. Shim, and S.-J. Chung Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats: evidence for the involvement of nuclear factor-κB, a nitrosative stress-sensitive transcription factor, in the regulation Drug Metab. Dispos. 35 2007 1996 2005
22. M. Motojima, F. Nishijima, M. Ikoma, T. Kawamura, T. Yoshioka, A.B. Fogo, T. Sakai, and I. Ichikawa Role for uremic toxin in the progressive loss of intact nephrons in chronic renal failure Kidney Int. 40 1991 461 469
23. C.A. Naughton Drug-induced nephrotoxicity Am Fam. Physician 78 2008 743 750
24. A. Nawa, W. Fujita, and S. Tokuyama Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions Life Sci. 86 2010 402 409
25. M. Piquette-Miller, A. Pak, H. Kim, R. Anari, and A. Shahzamani Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation Pharm. Res. 15 1998 706 711
26. J.C. Richardson, V. Scalera, and N.L. Simmons Identification of two strains of MDCK cells which resemble separate nephron tubule segments Biochim. Biophys. Acta 673 1981 26 36
27. S.J. Robertson, K.D. Kania, S.B. Hladky, and M.A. Barrand P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation J. Neurochem. 111 2009 132 141
28. C.W. Sachs, T.C. Chambers, and R.L. Fine Differential phosphorylation of sites in the linker region of P-glycoprotein by protein kinase C isozymes a, βI, βII, γ, δ, ε, η, and Biochem. Pharmacol. 58 1999 1587 1592
29. O.F. Santos, L.A. Moura, E.M. Rosen, and S.K. Nigam Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms Dev. Biol. 159 1993 535 548
30. A.H. Schinkel, and J.W. Jonker Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Adv. Drug Deliver. Rev. 55 2003 3 29
31. K. Sekizuka, Y. Tomino, C. Sei, A. Kurusu, K. Tashiro, Y. Yamaguchi, S. Kodera, T. Hishiki, I. Shirato, and H. Koide Detection of serum IL-6 in patients with diabetic nepphropahty Nephron 68 1994 284 285
32. J. Spranger, A. Kroke, M. Mohlig, K. Hoffmann, M.M. Bergmann, M. Ristow, H. Boeing, and A.F.H. Pfeiffer Inflammatory cytokines and the risk to develop type 2 diabetes Diabetes 52 2003 812 817
33. K. Svennevig, K. Prydz, and S.O. Kolset Proteoglycans in polarized epithelial Madin-Darby canine kidney cells Biochem. J. 311 1995 881 888
34. G. Tramonti, P. Xie, E.I. Wallner, F.R. Danesh, and Y.S. Kanwar Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1 and PEPT2 in renal mass reduction and diabetes Am. J. Physiol. Renal Physiol. 291 2006 F972 F980
35. M. Wartenberg, F.C. Ling, M. Schallenberg, A.T. Bäumer, K. Petrat, J. Hescheler, and H. Sauer Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive species J. Biol. Chem. 276 2001 17420 17428
36. M. Wartenberg, M. Richter, A. Datchev, S. Günther, N. Milosevic, M.M. Bekhite, H.-R. Figulla, J.M. Aran, J. Pétriz, and H. Sauer Glycolytic pyruvate regulates P-glycoprotein expression in multicellular tumor spheroids via modulation of the intracellular redox state J. Cell. Biochem. 109 2010 434 446
37. K.C. Wu, H.J. Pan, H.S. Yin, M.R. Chen, S.C. Lu, and C.J. Lin Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand Obese mice with type 2 diabetes Life Sci. 85 2009 775 781
38. Q. Zhong, S.R. Terlecky, and L.H. Lash Diabetes increases susceptibility of primary cultures of rat proximal tubular cells to chemically induced injury Toxicol. Appl. Pharmacol. 241 2009 1 13